ATP6AP1
V-type proton ATPase subunit S1
Also known as: 16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VAS1_HUMAN, VATPS1, XAP-3, XAP3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15904
- Gene
- ATP6AP1
- Ensembl
- ENSG00000071553
- Chromosome
- X
- Canonical length
- 470 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a component of a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. Vacuolar ATPase (V-ATPase) is comprised of a cytosolic V1 (site of the ATP catalytic site) and a transmembrane V0 domain. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, and receptor-mediated endocytosis. The encoded protein of this gene may assist in the V-ATPase-mediated acidification of neuroendocrine secretory granules. This protein may also play a role in early development. [provided by RefSeq, Aug 2013]
Canonical amino-acid sequenceUniProt
470 residues, UniProt reviewed canonical sequence.
>Q15904|ATP6AP1
1 MMAAMATARV RMGPRCAQAL WRMPWLPVFL SLAAAAAAAA AEQQVPLVLW SSDRDLWAPA
61 ADTHEGHITS DLQLSTYLDP ALELGPRNVL LFLQDKLSIE DFTAYGGVFG NKQDSAFSNL
121 ENALDLAPSS LVLPAVDWYA VSTLTTYLQE KLGASPLHVD LATLRELKLN ASLPALLLIR
181 LPYTASSGLM APREVLTGND EVIGQVLSTL KSEDVPYTAA LTAVRPSRVA RDVAVVAGGL
241 GRQLLQKQPV SPVIHPPVSY NDTAPRILFW AQNFSVAYKD QWEDLTPLTF GVQELNLTGS
301 FWNDSFARLS LTYERLFGTT VTFKFILANR LYPVSARHWF TMERLEVHSN GSVAYFNASQ
361 VTGPSIYSFH CEYVSSLSKK GSLLVARTQP SPWQMMLQDF QIQAFNVMGE QFSYASDCAS
421 FFSPGIWMGL LTSLFMLFIF TYGLHMILSL KTMDRFDDHK GPTISLTQIVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP6AP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 214 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 214 nTPM
- parathyroid gland: 165 nTPM
- cerebral cortex: 149 nTPM
- cerebellum: 141 nTPM
- epididymis: 137 nTPM
- hypothalamus: 120 nTPM
Single-cell type
- esophageal apical cells: 334 nCPM
- hofbauer cells: 310 nCPM
- syncytiotrophoblasts: 231 nCPM
- kupffer cells: 182 nCPM
- cytotrophoblasts: 160 nCPM
- neutrophils: 147 nCPM
Immune cell
- myeloid DC: 377 nTPM
- eosinophil: 365 nTPM
- neutrophil: 328 nTPM
- intermediate monocyte: 314 nTPM
- classical monocyte: 296 nTPM
- non-classical monocyte: 257 nTPM
Brain region
- choroid plexus: 170 nTPM
- white matter: 165 nTPM
- pons: 163 nTPM
- cerebral cortex: 153 nTPM
- hypothalamus: 152 nTPM
- basal ganglia: 135 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP6AP1.
Disease | AllUniProt
Conditions ATP6AP1 is implicated in, by any mechanism.
- Immunodeficiency 47 (IMD47) MIM:300972
Disease | GeneticClinVar
13 pathogenic / likely-pathogenic of 401 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency 47
Disease | ImmuneIEDB
Conditions an epitope on ATP6AP1 was assayed in.
- melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.21
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 1.53
- DepMap mean gene effect
- -0.97
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to increased oxygen levels
- endosomal lumen acidification
- endosome to plasma membrane protein transport
- Golgi lumen acidification
- intracellular iron ion homeostasis
- intracellular pH reduction
- lysosomal lumen acidification
- osteoclast development
- proton transmembrane transport
- regulation of cellular pH
- synaptic vesicle lumen acidification
- vacuolar acidification
Molecular functions
Cellular components
- clathrin-coated vesicle membrane
- endoplasmic reticulum membrane
- endoplasmic reticulum-Golgi intermediate compartment membrane
- endosome membrane
- extracellular exosome
- Golgi membrane
- lysosomal membrane
- membrane
- plasma membrane
- proton-transporting two-sector ATPase complex
- proton-transporting V-type ATPase complex
- synaptic vesicle membrane
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP6AP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP6AP1 as an antibody target. Whether an autoantibody or antibody against ATP6AP1 could matter depends on whether native ATP6AP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP6AP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATP6AP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...